
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $417.6M | $456.3M | $481.3M | $459M | $476M | |
Revenue Growth (YoY) | -23.52% | 9.25% | 5.5% | -4.65% | 3.7% | |
Cost of Revenues | $359.2M | $415M | $392.8M | $353.1M | $335.4M | |
Gross Profit | $58.4M | $41.3M | $88.6M | $105.9M | $140.5M | |
Gross Profit Margin | 14% | 9.05% | 18.4% | 23.07% | 29.53% | |
R&D Expenses | $25.4M | $22.4M | $18.9M | $19.5M | $20.1M | |
Selling, General & Admin | $51.7M | $57.9M | $42.9M | $40.4M | $37.4M | |
Other Inc / (Exp) | $743K | -$1K | -- | -- | -- | |
Operating Expenses | $80.2M | $82.8M | $64M | $61.6M | $58.9M | |
Operating Income | -$21.7M | -$41.6M | $24.6M | $44.3M | $81.6M | |
Net Interest Expenses | $5.7M | $7.3M | $13M | $17.1M | $11.4M | |
EBT. Incl. Unusual Items | -$26.7M | -$48.9M | $11.6M | $27.2M | $70.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$3.7M | -$406K | $304K | $900K | $922K | |
Net Income to Company | -$23M | -$48.5M | $11.3M | $26.3M | $69.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$23M | -$48.5M | $11.3M | $26.3M | $69.3M | |
Basic EPS (Cont. Ops) | -$1.00 | -$2.12 | $0.49 | $1.15 | $3.01 | |
Diluted EPS (Cont. Ops) | -$1.00 | -$2.12 | $0.49 | $1.15 | $3.01 | |
Weighted Average Basic Share | $22.9M | $22.9M | $22.9M | $23M | $23M | |
Weighted Average Diluted Share | $22.9M | $22.9M | $22.9M | $23M | $23M | |
EBITDA | -$12.8M | -$34.2M | $31.3M | $49.9M | $86.8M | |
EBIT | -$21M | -$41.6M | $24.6M | $44.3M | $81.6M | |
Revenue (Reported) | $417.6M | $456.3M | $481.3M | $459M | $476M | |
Operating Income (Reported) | -$21.7M | -$41.6M | $24.6M | $44.3M | $81.6M | |
Operating Income (Adjusted) | -$21M | -$41.6M | $24.6M | $44.3M | $81.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $100.2M | $98.9M | $116.5M | $95.2M | $135.4M | |
Revenue Growth (YoY) | -4.69% | -1.22% | 17.71% | -18.23% | 42.22% | |
Cost of Revenues | $93.1M | $82.2M | $93M | $69.5M | $95.2M | |
Gross Profit | $7.1M | $16.7M | $23.5M | $25.8M | $40.3M | |
Gross Profit Margin | 7.06% | 16.9% | 20.15% | 27.04% | 29.75% | |
R&D Expenses | $6.2M | $4.6M | $4.6M | $5.2M | $4.2M | |
Selling, General & Admin | $15.8M | $11.4M | $9.9M | $9.5M | $11.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $22.7M | $16.5M | $14.9M | $15.1M | $15.7M | |
Operating Income | -$15.6M | $232K | $8.5M | $10.7M | $24.6M | |
Net Interest Expenses | $2.2M | $2.4M | $4.7M | $3.3M | $1.8M | |
EBT. Incl. Unusual Items | -$17.8M | -$2.2M | $3.9M | $7.3M | $22.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $390K | $386K | $135K | $201K | $3.8M | |
Net Income to Company | -$18.2M | -$2.6M | $3.7M | $7.1M | $19.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$18.2M | -$2.6M | $3.7M | $7.1M | $19.1M | |
Basic EPS (Cont. Ops) | -$0.79 | -$0.11 | $0.16 | $0.31 | $0.83 | |
Diluted EPS (Cont. Ops) | -$0.79 | -$0.11 | $0.16 | $0.31 | $0.83 | |
Weighted Average Basic Share | $22.9M | $22.9M | $23M | $23M | $23M | |
Weighted Average Diluted Share | $22.9M | $22.9M | $23M | $23M | $23.1M | |
EBITDA | -$13.7M | $2M | $10M | $12M | $25.9M | |
EBIT | -$15.6M | $232K | $8.5M | $10.7M | $24.6M | |
Revenue (Reported) | $100.2M | $98.9M | $116.5M | $95.2M | $135.4M | |
Operating Income (Reported) | -$15.6M | $232K | $8.5M | $10.7M | $24.6M | |
Operating Income (Adjusted) | -$15.6M | $232K | $8.5M | $10.7M | $24.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $412.7M | $455M | $498.9M | $437.7M | $516.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $364.9M | $404.1M | $403.5M | $329.6M | $361.1M | |
Gross Profit | $47.8M | $50.9M | $95.3M | $108.2M | $155.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $24.8M | $20.8M | $18.9M | $20.1M | $19.1M | |
Selling, General & Admin | $53.7M | $53.4M | $41.5M | $40M | $39M | |
Other Inc / (Exp) | $532K | -$1K | -- | -- | -- | |
Operating Expenses | $81.4M | $76.7M | $62.4M | $61.7M | $59.5M | |
Operating Income | -$33.6M | -$25.7M | $32.9M | $46.4M | $95.6M | |
Net Interest Expenses | $6.6M | $7.6M | $15.2M | $15.8M | $9.9M | |
EBT. Incl. Unusual Items | -$39.7M | -$33.3M | $17.6M | $30.7M | $85.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $719K | -$410K | $53K | $966K | $4.5M | |
Net Income to Company | -$40.4M | -$32.9M | $17.6M | $29.7M | $81.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$40.4M | -$32.9M | $17.6M | $29.7M | $81.2M | |
Basic EPS (Cont. Ops) | -$1.76 | -$1.43 | $0.76 | $1.30 | $3.53 | |
Diluted EPS (Cont. Ops) | -$1.76 | -$1.43 | $0.76 | $1.30 | $3.53 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$25.1M | -$18.5M | $39.3M | $54.4M | $103.8M | |
EBIT | -$33.1M | -$25.7M | $32.9M | $46.4M | $95.6M | |
Revenue (Reported) | $412.7M | $455M | $498.9M | $437.7M | $516.2M | |
Operating Income (Reported) | -$33.6M | -$25.7M | $32.9M | $46.4M | $95.6M | |
Operating Income (Adjusted) | -$33.1M | -$25.7M | $32.9M | $46.4M | $95.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $100.2M | $98.9M | $116.5M | $95.2M | $135.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $93.1M | $82.2M | $93M | $69.5M | $95.2M | |
Gross Profit | $7.1M | $16.7M | $23.5M | $25.8M | $40.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $6.2M | $4.6M | $4.6M | $5.2M | $4.2M | |
Selling, General & Admin | $15.8M | $11.4M | $9.9M | $9.5M | $11.1M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $22.7M | $16.5M | $14.9M | $15.1M | $15.7M | |
Operating Income | -$15.6M | $232K | $8.5M | $10.7M | $24.6M | |
Net Interest Expenses | $2.2M | $2.4M | $4.7M | $3.3M | $1.8M | |
EBT. Incl. Unusual Items | -$17.8M | -$2.2M | $3.9M | $7.3M | $22.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $390K | $386K | $135K | $201K | $3.8M | |
Net Income to Company | -$18.2M | -$2.6M | $3.7M | $7.1M | $19.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$18.2M | -$2.6M | $3.7M | $7.1M | $19.1M | |
Basic EPS (Cont. Ops) | -$0.79 | -$0.11 | $0.16 | $0.31 | $0.83 | |
Diluted EPS (Cont. Ops) | -$0.79 | -$0.11 | $0.16 | $0.31 | $0.83 | |
Weighted Average Basic Share | $22.9M | $22.9M | $23M | $23M | $23M | |
Weighted Average Diluted Share | $22.9M | $22.9M | $23M | $23M | $23.1M | |
EBITDA | -$13.7M | $2M | $10M | $12M | $25.9M | |
EBIT | -$15.6M | $232K | $8.5M | $10.7M | $24.6M | |
Revenue (Reported) | $100.2M | $98.9M | $116.5M | $95.2M | $135.4M | |
Operating Income (Reported) | -$15.6M | $232K | $8.5M | $10.7M | $24.6M | |
Operating Income (Adjusted) | -$15.6M | $232K | $8.5M | $10.7M | $24.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $21M | $6.3M | $24.3M | $22.8M | $55.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $60.1M | $65.1M | $89.9M | $67M | $69M | |
Inventory | $108.2M | $142.2M | $120.6M | $84.9M | $93.9M | |
Prepaid Expenses | -- | -- | -- | $8.5M | $6.4M | |
Other Current Assets | $6.4M | $8.9M | $16.4M | $2.2M | $4.2M | |
Total Current Assets | $202.7M | $230.2M | $255.3M | $205.4M | $254.3M | |
Property Plant And Equipment | $20.2M | $30.9M | $27.1M | $42.1M | $38.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $29.8M | $29.8M | $29.8M | $29.8M | $29.8M | |
Other Intangibles | $10.3M | $7.8M | $5.7M | $3.9M | $2.5M | |
Other Long-Term Assets | $21M | $1.8M | $2M | $3.1M | $2.9M | |
Total Assets | $284M | $300.5M | $319.9M | $284.3M | $328.2M | |
Accounts Payable | $31.5M | $93.3M | $76.4M | $67.4M | $58.2M | |
Accrued Expenses | $19.6M | $23.7M | $22.5M | $16.8M | $17.5M | |
Current Portion Of Long-Term Debt | -- | $25.1M | $75.7M | $95M | $25.7M | |
Current Portion Of Capital Lease Obligations | $4.1M | $4.1M | $3M | $4M | $4.6M | |
Other Current Liabilities | -- | -- | -- | $41K | $1.8M | |
Total Current Liabilities | $239.5M | $283.3M | $319.3M | $248.3M | $227.6M | |
Long-Term Debt | -- | $25.4M | $5M | $90K | $38K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $277.9M | $342.6M | $350.3M | $288.2M | $262.9M | |
Common Stock | $23K | $23K | $23K | $23K | $23K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $6.1M | -$42M | -$30.4M | -$3.9M | $65.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $6.1M | -$42M | -$30.4M | -$3.9M | $65.3M | |
Total Liabilities and Equity | $284M | $300.5M | $319.9M | $284.3M | $328.2M | |
Cash and Short Terms | $21M | $6.3M | $24.3M | $22.8M | $55.3M | |
Total Debt | $130M | $180.5M | $210.8M | $145M | $120.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $23.4M | $2.3M | $26.9M | $33.1M | $50M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $52.5M | $71.3M | $83.1M | $49.3M | $81.6M | |
Inventory | $109.1M | $139.1M | $132.3M | $88.8M | $116.8M | |
Prepaid Expenses | -- | -- | -- | -- | $6.4M | |
Other Current Assets | $8.1M | $11.3M | $18.6M | $34.3M | $2.4M | |
Total Current Assets | $200.1M | $231.5M | $265.2M | $209.1M | $278.2M | |
Property Plant And Equipment | $19.4M | $16M | $25.6M | $41.3M | $59.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $29.8M | $29.8M | $29.8M | $29.8M | $29.8M | |
Other Intangibles | $9.7M | $7.2M | $5.2M | $3.5M | $2.1M | |
Other Long-Term Assets | $20M | $14.4M | $2M | $3.1M | $2.9M | |
Total Assets | $279.1M | $299M | $327.8M | $286.8M | $372.7M | |
Accounts Payable | $55.2M | $82.6M | $79.7M | $72.8M | $66.2M | |
Accrued Expenses | $22.4M | $23.8M | $24.4M | $16.8M | $20.2M | |
Current Portion Of Long-Term Debt | $292K | $40.2M | $80M | $94.9M | $15.8M | |
Current Portion Of Capital Lease Obligations | $3.8M | $4M | $2.5M | $4.2M | $5.2M | |
Other Current Liabilities | -- | -- | -- | -- | $1.7M | |
Total Current Liabilities | $251.9M | $289.3M | $327.2M | $245.8M | $239.5M | |
Long-Term Debt | $695K | $25.6M | $195K | $77K | $24K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $291M | $343.4M | $354.4M | $283.6M | $288.4M | |
Common Stock | $23K | $23K | $23K | $23K | $23K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$11.9M | -$44.4M | -$26.6M | $3.2M | $84.3M | |
Total Liabilities and Equity | $279.1M | $299M | $327.8M | $286.8M | $372.7M | |
Cash and Short Terms | $23.4M | $2.3M | $26.9M | $33.1M | $50M | |
Total Debt | $131M | $195.8M | $210.1M | $140M | $110.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$23M | -$48.5M | $11.3M | $26.3M | $69.3M | |
Depreciation & Amoritzation | $8.2M | $7.4M | $6.7M | $5.6M | $5.2M | |
Stock-Based Compensation | $607K | $394K | $385K | $151K | $89K | |
Change in Accounts Receivable | $44.6M | -$5M | -$22M | $9.3M | -$4.2M | |
Change in Inventories | -$382K | -$34.8M | $21.1M | $33.8M | -$10.6M | |
Cash From Operations | -$7.6M | -$61.5M | -$8.8M | $70.5M | $62.4M | |
Capital Expenditures | $2.4M | $2M | $1.4M | $5M | $4.6M | |
Cash Acquisitions | -- | $2.3M | -- | -- | -- | |
Cash From Investing | -$1.4M | $398K | -$1.4M | -$5M | -$4.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $180.3M | $51.3M | $31.6M | $15M | $100M | |
Long-Term Debt Repaid | -$145.1M | -$1.6M | -$1.4M | -$80.8M | -$125M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.9M | -$3.2M | -$1.8M | -$989K | -$910K | |
Cash From Financing | $33.3M | $46.5M | $28.4M | -$66.8M | -$25.9M | |
Beginning Cash (CF) | $3K | $24.3M | $9.7M | $27.9M | $26.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $24.3M | -$14.5M | $18.2M | -$1.3M | $31.9M | |
Ending Cash (CF) | $24.3M | $9.7M | $27.9M | $26.6M | $58.5M | |
Levered Free Cash Flow | -$10M | -$63.4M | -$10.2M | $65.5M | $57.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$18.2M | -$2.6M | $3.7M | $7.1M | $19.1M | |
Depreciation & Amoritzation | $1.9M | $1.7M | $1.4M | $1.3M | $1.3M | |
Stock-Based Compensation | $109K | $203K | $69K | $26K | $153K | |
Change in Accounts Receivable | $7.6M | -$6.1M | $6.4M | $12.4M | -$7.6M | |
Change in Inventories | -$1.4M | $3.2M | -$12.6M | -$4.8M | -$19.3M | |
Cash From Operations | $5.7M | -$17.4M | $5M | $15.6M | $8.8M | |
Capital Expenditures | $617K | $116K | $612K | $815K | $3.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$607K | -$116K | -$612K | -$815K | -$3.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $15M | -- | -- | -- | |
Long-Term Debt Repaid | -$102K | -$87K | -$647K | -$5.1M | -$10.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.5M | -$1.7M | -$986K | -$130K | -$142K | |
Cash From Financing | -$2.6M | $13.2M | -$1.6M | -$5.2M | -$10.2M | |
Beginning Cash (CF) | $24.3M | $9.7M | $27.9M | $26.6M | $58.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.4M | -$4.3M | $2.8M | $9.6M | -$4.8M | |
Ending Cash (CF) | $26.7M | $5.4M | $30.7M | $36.2M | $53.7M | |
Levered Free Cash Flow | $5.1M | -$17.5M | $4.4M | $14.8M | $5.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$40.4M | -$32.9M | $17.6M | $29.7M | $81.2M | |
Depreciation & Amoritzation | $8M | $7.3M | $6.4M | $5.5M | $5.2M | |
Stock-Based Compensation | $559K | $488K | $251K | $108K | $216K | |
Change in Accounts Receivable | $6.6M | -$18.7M | -$9.4M | $15.3M | -$24.1M | |
Change in Inventories | $15.1M | -$30.3M | $5.3M | $41.6M | -$25.1M | |
Cash From Operations | -$26.2M | -$84.5M | $13.5M | $81.1M | $55.6M | |
Capital Expenditures | $2.2M | $1.5M | $1.9M | $5.2M | $7.1M | |
Cash Acquisitions | -- | $2.3M | -- | -- | -- | |
Cash From Investing | -$1.2M | $889K | -$1.9M | -$5.2M | -$7.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $52.7M | $66.3M | -- | -- | -- | |
Long-Term Debt Repaid | $5M | -$1.5M | -$2M | -$85.2M | -$130.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.4M | -$2.4M | -$1.1M | -$133K | -$922K | |
Cash From Financing | $53.4M | $62.4M | $13.5M | -$70.3M | -$31M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $25.9M | -$21.3M | $25.2M | $5.6M | $17.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$28.5M | -$86M | $11.7M | $75.9M | $48.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$18.2M | -$2.6M | $3.7M | $7.1M | $19.1M | |
Depreciation & Amoritzation | $1.9M | $1.7M | $1.4M | $1.3M | $1.3M | |
Stock-Based Compensation | $109K | $203K | $69K | $26K | $153K | |
Change in Accounts Receivable | $7.6M | -$6.1M | $6.4M | $12.4M | -$7.6M | |
Change in Inventories | -$1.4M | $3.2M | -$12.6M | -$4.8M | -$19.3M | |
Cash From Operations | $5.7M | -$17.4M | $5M | $15.6M | $8.8M | |
Capital Expenditures | $617K | $116K | $612K | $815K | $3.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$607K | -$116K | -$612K | -$815K | -$3.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $15M | -- | -- | -- | |
Long-Term Debt Repaid | -$102K | -$87K | -$647K | -$5.1M | -$10.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.5M | -$1.7M | -$986K | -$130K | -$142K | |
Cash From Financing | -$2.6M | $13.2M | -$1.6M | -$5.2M | -$10.2M | |
Beginning Cash (CF) | $24.3M | $9.7M | $27.9M | $26.6M | $58.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $2.4M | -$4.3M | $2.8M | $9.6M | -$4.8M | |
Ending Cash (CF) | $26.7M | $5.4M | $30.7M | $36.2M | $53.7M | |
Levered Free Cash Flow | $5.1M | -$17.5M | $4.4M | $14.8M | $5.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.